Adrafinil is a wakefulness-promoting nootropic compound known for its ability to increase alertness, focus, and mental clarity. It is commonly used to combat fatigue, improve cognitive performance, and enhance motivation. Adrafinil acts as a prodrug to Modafinil, meaning it is converted into Modafinil in the body, leading to its stimulant-like effects.
For a more detailed description and lab analysis, please see the sections below.
From €32.08
Adrafinil is a synthetic eugeroic compound, meaning it promotes wakefulness without causing the overstimulation typical of traditional stimulants. Originally developed in France in the 1970s, Adrafinil is metabolized in the liver into Modafinil, a well-known prescription drug used for treating sleep disorders like narcolepsy and for improving wakefulness. Adrafinil is often taken by those seeking to increase focus, reduce fatigue, and enhance cognitive performance over extended periods of time.
Adrafinil is sometimes considered as functional in athletes for use as a stimulant. As a result, it is a banned substance in competitive sports – banned by the World Anti-Doping Agency (WADA) for its stimulant-like effects.
Adrafinil works by modulating dopaminergic and noradrenergic systems, increasing the availability of dopamine and norepinephrine in the brain. These neurotransmitters are responsible for improving alertness, focus, and mood, making Adrafinil effective for maintaining productivity and mental clarity during mentally demanding tasks.
Adrafinil is a prodrug, meaning it is converted into Modafinil after being processed by the liver. Once converted, Modafinil enhances the activity of several neurotransmitters:
For detailed lab analysis and product specifications, please refer to the next tabs.
Adrafinil is a synthetic eugeroic compound, meaning it promotes wakefulness without causing the overstimulation typical of traditional stimulants. Originally developed in France in the 1970s, Adrafinil is metabolized in the liver into Modafinil, a well-known prescription drug used for treating sleep disorders like narcolepsy and for improving wakefulness. Adrafinil is often taken by those seeking to increase focus, reduce fatigue, and enhance cognitive performance over extended periods of time.
Adrafinil is sometimes considered as functional in athletes for use as a stimulant. As a result, it is a banned substance in competitive sports – banned by the World Anti-Doping Agency (WADA) for its stimulant-like effects.
Adrafinil works by modulating dopaminergic and noradrenergic systems, increasing the availability of dopamine and norepinephrine in the brain. These neurotransmitters are responsible for improving alertness, focus, and mood, making Adrafinil effective for maintaining productivity and mental clarity during mentally demanding tasks.
Adrafinil is a prodrug, meaning it is converted into Modafinil after being processed by the liver. Once converted, Modafinil enhances the activity of several neurotransmitters:
For detailed lab analysis and product specifications, please refer to the next tabs.
| Technical Information | |
|---|---|
| CAS Number | 63547-13-7 |
| PubChem CID | 3033226 |
| Purity | ≥98% |
| Molecular Weight | 289.35 g/mol |
| Molecular Formula | C₁₅H₁₅NO₃S |
| Melting Point | 150–160°C (dec.) |
| Synonyms | Olmifon, CRL 40028, 2-(Benzhydrylsulfinyl)acetohydroxamic acid, 2-[(Diphenylmethyl)sulfinyl]-N-hydroxyacetamide, 2-[(Diphenylmethyl)sulfinyl]acetohydroxamic acid |
| SMILES Notation | O=S(C(c1ccccc1)c2ccccc2)CC(=O)NO |
| Application | Adrafinil is an eugeroic agent with wakefulness-promoting effects in vivo. |
| Appearance | Pale pink, light pink, or pink powder |
| Physical State | Solid |
| Solubility | – Slightly soluble in water – Soluble in methanol and DMSO (>35 mg/mL) |
| Storage Conditions | Store at room temperature or cooler, in a sealed airtight container, protected from heat, light, and humidity. |
| Stability | Stable for at least two years when stored as above. |
